Enlivex Therapeutics Ltd.

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Medical Specialties
TMOThermo Fisher Scientific, Inc. 0.97%508.021.0%$739.78m
DHRDanaher Corp. -0.01%236.720.7%$544.62m
ABTAbbott Laboratories 1.40%112.860.8%$449.21m
MDTMedtronic Plc 1.41%118.460.6%$405.98m
ISRGIntuitive Surgical, Inc. 0.46%782.002.3%$402.46m
BSXBoston Scientific Corp. -0.26%36.241.0%$348.19m
DXCMDexCom, Inc. 1.31%358.867.8%$330.77m
BDXBecton, Dickinson & Co. -0.36%260.791.0%$279.92m
SYKStryker Corp. 0.34%242.801.3%$218.29m
ALGNAlign Technology, Inc. -0.92%562.036.4%$204.78m
AAgilent Technologies, Inc. 0.43%126.751.6%$196.01m
QDELQuidel Corp. -1.73%200.967.7%$194.04m
EWEdwards Lifesciences Corp. 0.48%88.290.4%$176.03m
BAXBaxter International, Inc. -1.79%78.611.8%$172.43m
IDXXIDEXX Laboratories, Inc. -0.58%486.633.8%$161.15m

Company Profile

Enlivex Therapeutics Ltd. develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions. It produces treatment devices for CAR-T cancer treatment procedures, Graft-versus-Host disease resulting from bone-marrow transplantations, solid organ transplantations and an assembly of autoimmune and inflammatory conditions, such as Crohn's disease, rheumatoid arthritis, gout, multiple sclerosis and other disorders. The company is headquartered in Nes-Ziona, Israel.